New hope for tough cancers: experimental drug VIB305 enters human trials
Disease control
Recruiting now
This study tests an experimental drug called VIB305 in people with advanced solid tumors that have not responded to or cannot be treated with standard therapies. The trial has two parts: first, finding the safest dose, and then testing that dose in more patients to see if it shri…
Phase: PHASE1, PHASE2 • Sponsor: Vibrant Sciences Limited • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC